Prevention of pathology in mdx mice by expression of utrophin: Analysis using an inducible transgenic expression system

Human Molecular Genetics

Volumn 11, Issue 26, 2002, Pages 3333-3344

  Squire, S ^a   Raymackers, J M ^b   Vandebrouck, C ^b   Potter, A ^a   Tinsley, J ^a,c   Fisher, R ^a   Gillis, J M ^b   Davies, Kay E ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^c Oxagen Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CYTOSKELETON PROTEIN; DYSTROPHIN; SARCOGLYCAN; TETRACYCLINE; UTROPHIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIRTH; CALCIUM CURRENT; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC MARKER; HISTOLOGY; MOSAICISM; MOUSE; MUSCLE ISOMETRIC CONTRACTION; MUSCLE NECROSIS; NONHUMAN; PATHOGENESIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; SYMPTOMATOLOGY; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CALCIUM CHANNELS; CYTOSKELETAL PROTEINS; DIAPHRAGM; GENE THERAPY; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCULAR DYSTROPHY, DUCHENNE; TIME FACTORS; UTROPHIN;

ANIMALIA; MUS MUSCULUS;

EID: 12244272395     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/11.26.3333     Document Type: Review

References (43)

1. Blake, D.J., Weir, A., Newey, S.E. and Davies, K.E. (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol. Rev., 82, 291-329.
2. Harper, S.Q., Hauser, M.A., DelloRusso, C., Duan, D., Crawford, R.W Phelps, S.F., Harper, H.A., Robinson, A.S., Engelhardt, J.F., Brooks, S.V. et al. (2002) Modular flexibility of dystrophin: Implications for gene therapy of Duchenne muscular dystrophy. Nat. Med., 8, 253-261.
3. Hartigan-O'Connor, D. and Chamberlain, J.S. (2000) Developments in gene therapy for muscular dystrophy. Microsc. Res. Techn., 48, 223-238.
4. Chamberlain, J.S. (2002) Gene therapy of muscular dystrophy. Hum. Mol. Genet., 11, 2355- 2362.
5. van Deutekom, J.C., Bremmer-Bout, M., Janson, A.A., Ginjaar, I.B., Baas, F, den Dunnen, J.T. and van Ommen, G.J. (2001) Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells. Hum. Mol. Genet., 10, 1547-1554.
6. Mann, C.J., Honeyman, K., Cheng, A.J., Ly, T, Lloyd, F., Fletcher, S., Morgan, J.E., Partridge, T.A. and Wilton, S.D. (2001) Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse. Proc. Natl Acad. Sci. USA, 98, 42-47.
7. Bertoni, C. and Rando, T.A. (2002) Dystrophin gene repair in mdx muscle precursor cells in vitro and in vivo mediated by RNA-DNA chimeric oligonucleotides. Hum. Gene Ther, 13, 707-718.
8. Kapsa, R., Quigley, A., Lynch, G.S., Steeper, K., Kornberg, A.J., Gregorevic, P., Austin, L. and Byrne, E. (2001) In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement. Hum. Gene Ther, 12, 629-642.
9. Tinsley, J.M., Potter, A.C., Phelps, S.R., Fisher, R., Trickett, J.I., Davies, K.E. (1996) Amelioration of the dystrophic phenotype of mdx using a truncated utrophin transgene. Nature, 384, 349-353.
10. Deconinck, N., Tinsley, J., De Backer, F., Fisher, R., Kahn, D., Phelps, S., Davies, K. and Gillis, J.-M. (1997) Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nat. Med., 3, 1216-1221.
11. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J.M. and Davies, K.E. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat. Med., 4, 1441-1444.
12. Fisher, R., Tinsley, J.M., Phelps, S.R., Squire, S.E., Townsend E.R., Martin, J.E. and Davies, K.E. (2001) Non-toxic ubiquitous over-expression of utrophin in the mdx mouse. Neuromusc. Disord., 11, 713-721.
13. Wakefield, P.M., Tinsley, J.M., Wood, M.J.A., Gilbert, R., Karpati, G. and Davies, K.E. (2000) Prevention of the dystrophic phenotype in dystrophin/ utrophin-deficient muscle following adenoviral-mediated transfer of a utrophin minigene. Gene Ther, 7, 201-204.
14. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
15. Jaynes, J.B., Chamberlain, J.S., Buskin, J.N., Johnson, J.E and Hauschka, S.D. (1986) Transcriptional regulation of the muscle creatine kinase gene and regulated expression in transfected mouse myoblasts. Mol. Cell. Biol., 6, 2855- 2864.
16. Johnson, J.E., Wold, B.J. and Hauschka, S.D. (1989) Muscle creatine kinase sequence elements regulating skeletal and cardiac expression in transgenic mice. Mol. Cell Biol., 9, 3393-3399.
17. Amacher, S.L., Buskin, J.N. and Hauschka, S.D. (1993) Multiple regulatory elements contribute differentially to muscle creatine kinase enhancer activity in skeletal and cardiac muscle. Mol. Cell Biol., 13, 2753-2764.
18. Duchenne, G.B.A. (1868) Recherches sur la paralysie musculaire pseudohypertrophique ou paralysie myo-sclérotique. Archives générales de Médecine, 11, 5-25, 179-209, 305-321, 421-443, 552-588.
19. Coulton, G.R., Morgan, J.E., Partridge, T.A. and Sloper, J.C. (1988) The mdx mouse skeletal muscle myopathy: I a histological, morphometric and biochemical investigation. Neuropath. Appl. Neurobiol., 14, 53-70.
20. Carlson, C.G. and Makiejus, R.V. (1990) A noninvasive procedure to detect muscle weakness in the mdx mouse. Mus. Ner., 13, 480-484.
21. Webster, C., Silberstein, L., Hays, A.P. and Blau, H.M. (1988) Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy. Cell, 52, 502-513.
22. Moens, P, Baatsen, P.H.W.W. and Maréchal, G. (1993) Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J. Musc. Res. Cell Mot., 14, 446-451.
23. Petrof, B.J., Shrager, J.B., Stedman, H.H., Kelly, A.M. and Sweeney, H.L. (1993) Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc. Natl Acad. Sci. USA, 90, 3710-3714.
24. Gillis, J.M. (1999) Understanding dystrophinopathies: an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse [In Process Citation]. J. Musc. Res. Cell Mot., 20, 605-625.
25. Turner, P.R., Fong, P., Denetclaw, W.F. and Steinhardt, R.A. (1991) Increased calcium influx in dystrophic muscle. J. Cell Biol., 115, 1701-1712.
26. Turner, P.R., Westwood, T., Regen, C.M. and Steinhardt, R.A. (1988) Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature, 355, 735-738.
27. Gailly, P., Boland, B., Himpens, B., Casteels, R. and Gillis, J.M. (1993) Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium, 14, 473-483.
28. Head, S.I. (1993) Membrane potential, resting calcium and calcium transients in isolated muscle fibres from normal and dystrophic mice. J. Physiol., 469, 11-19.
29. 2+ concentrations are not elevated in resting cultured muscle from Duchenne (DMD) patients and in mdx mouse muscle fibres. Pflügers Archives., 426, 499-505.
30. Collet, C., Allard, B., Tourneur, Y. and Jacquemond, V. (1999) Intracellular calcium signals measured with indo-1 in isolated skeletal muscle fibres from control and mdx mice. J. Physiol., 520, 417-429.
31. Denetclaw, W.F., Hopf, F.W, Cox, G.A., Chamberlain, J.S. and Steinhardt, R.A. (1994) Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation. Mol. Biol. Cell, 5, 1159-1167.
32. 2+ homeostasis and of survival in collagenase-isolated muscle fibres from normal and mdx mice. J. Physiol., 542, 855-865.
33. Rybakova, I.N., Patel, J.R., Davies, K.E. Yurchenco, P.D. and Ervasti, J.M. (2002) Utrophin binds laterally along actin filaments and can couple costameric actin with sarcolemma when overexpressed in dystrophin-deficient muscle. Mol. Biol. Cell., 13, 1512-1221.
34. Ahmad, A., Brinson, M., Hodges, B.L., Chamberlain, J.S. and Amalfitano, A. (2000) mdx mice inducibly expressing dystrophin provide insights into the potential of gene therapy for Duchenne muscular dystrophy. Hum. Mol. Genet., 9, 2507-2515.
35. Fong, P., Turner, P.R., Denetclaw, W.F. and Steinhardt, R.A. (1990) Increased activity of calcium leak channels in myotubes of Duchenne human and mdx mouse origin. Science, 250, 673-676.
36. Turner, P.R., Schultz, R., Ganguly, B. and Steinhardt, R.A. (1993) Proteolysis results in altered leak channel kinetics and elevated free calcium in mdx muscle. J. Memb. Biol., 133, 243-251.
37. Franco-Obregon, A. Jr. and Lansman, J.B. (1994) Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J. Physiol., 1, 299-309.
38. Ghersa, P., Gobert, R.P, Sattonnet-Roche, P., Richards, C.A., Merlo Pich, E. and Hooft van Huijsduijnen, R. (1998) Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor. Gene Ther., 5, 1213-1220.
39. Guo, W.X., Nichol, M. and Merlie, J.P. (1996) Cloning and expression of full length mouse utrophin: the differential association of utrophin and dystrophin with AChR clusters. FEBS Lett., 398, 259-264.
40. Maréchal, G. and Beckers-Bleukx, G. (1988) Force-velocity and myosin isozymes in muscles of dystrophic (mdx) mice. Archiv. Internat. Physiol. Biochim., 96, P16.
41. Deconinck, N., Ragot, T, Maréchal, G., Pérricaudet, M. and Gillis, J.M. (1996) Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl Acad. Sci. USA, 93, 3570-3574.
42. Hamill, O.P., Marty, A., Neher, E., Sakmann, B. and Sigworth, F.J. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Archives, 391, 85-100.
43. McCarter, G.C. and Steinhardt, R.A. (2000) Increased activity of calcium leak channels caused by proteolysis near sarcolemmal ruptures. J. Memb. Biol., 176, 169-174.